Literature DB >> 16361538

The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.

Koji Matsuzaki1, Guoren Deng, Hirofumi Tanaka, Sanjay Kakar, Soichiro Miura, Young S Kim.   

Abstract

PURPOSE: The relationship between global hypomethylation, chromosomal instability (CIN), and microsatellite instability (MSI) remains unclear in colorectal cancer. The aim of this study was to investigate the relationship between global methylation status, loss of heterozygosity (LOH), and MSI in sporadic colorectal cancer. EXPERIMENTAL
DESIGN: We determined global methylation levels in 80 sporadic colorectal cancers, 51 adjacent normal tissues, and 20 normal tissues using the long interspersed nucleotide elements-combined bisulfite restriction analysis method. We also analyzed 80 colorectal cancers for MSI status and LOH at chromosomes 5q21, 8p12-22, 17p13, and 18q21.
RESULTS: We identified 14 cases of MSI (17.5%) and 58 cases of LOH (72.5%). LOH was observed more frequently in microsatellite stable (MSS) cancers than in MSI cancers at all loci. Colorectal cancers showed significantly lower global methylation levels than did normal tissues (41.0+/-9.7% versus 54.3+/-6.5%; P<0.001). MSS cancers showed significantly lower global methylation levels when compared with MSI cancers (39.5+/-9.4% versus 48.2+/-8.2%; P=0.003). Tumors with global hypomethylation (with <or=40% of methylation levels) had a significantly increased number of chromosomal loci with LOH than did tumors without global hypomethylation (1.9 versus 0.9; P<0.001); 11 tumors (13.9%) lacked both MSI and LOH. This subgroup had significantly higher global methylation levels (46.8+/-8.7%) than did MSS cancers with LOH (38.0+/-9.0%; P=0.006).
CONCLUSIONS: These data showed a significant association between global hypomethylation and chromosomal instability in sporadic colorectal cancer. This suggests that global hypomethylation plays an important role in inducing genomic instability in colorectal carcinogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16361538     DOI: 10.1158/1078-0432.CCR-05-0859

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  55 in total

Review 1.  Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Authors:  Katsuhiko Nosho; Yoshifumi Baba; Noriko Tanaka; Kaori Shima; Marika Hayashi; Jeffrey A Meyerhardt; Edward Giovannucci; Glenn Dranoff; Charles S Fuchs; Shuji Ogino
Journal:  J Pathol       Date:  2010-12       Impact factor: 7.996

Review 2.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

Review 3.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

4.  Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer.

Authors:  Niyati Desai; Dipti Sajed; Kshitij S Arora; Alexander Solovyov; Mihir Rajurkar; Jacob R Bledsoe; Srinjoy Sil; Ramzi Amri; Eric Tai; Olivia C MacKenzie; Mari Mino-Kenudson; Martin J Aryee; Cristina R Ferrone; David L Berger; Miguel N Rivera; Benjamin D Greenbaum; Vikram Deshpande; David T Ting
Journal:  JCI Insight       Date:  2017-02-09

Review 5.  Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?

Authors:  Tamas A Gonda; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Semin Cell Dev Biol       Date:  2009-10-17       Impact factor: 7.727

Review 6.  Molecular alterations and biomarkers in colorectal cancer.

Authors:  William M Grady; Colin C Pritchard
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

Review 7.  Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

8.  Epimutations, inheritance and causes of aberrant DNA methylation in cancer.

Authors:  David Mossman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

9.  Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.

Authors:  Yoshifumi Baba; Curtis Huttenhower; Katsuhiko Nosho; Noriko Tanaka; Kaori Shima; Aditi Hazra; Eva S Schernhammer; David J Hunter; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Mol Cancer       Date:  2010-05-27       Impact factor: 27.401

10.  Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.

Authors:  Graham M Poage; Brock C Christensen; E Andres Houseman; Michael D McClean; John K Wiencke; Marshall R Posner; John R Clark; Heather H Nelson; Carmen J Marsit; Karl T Kelsey
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.